A novel formulation of calcipotriene (CAL), betamethasone dipropionate (BDP) cream was found to be more effective, provide superior quality of life, and safe in patients with psoriasis, compared with ...
Akorn, a leading specialty pharmaceutical company, has received the Food and Drug Administration’s clearance for betamethasone dipropionate lotion (augmented), 0.05%. Betamethasone dipropionate lotion ...
Sign up for our newsletter to get the latest on the transformative forces shaping the global economy, delivered every Thursday.
SAN FRANCISCO (MarketWatch) -- Taro Pharmaceutical Industries Ltd. said Thursday its U.S. affiliate, Taro Pharmaceuticals U.S.A. Inc., has received tentative Food and Drug Administration approval for ...
BUENA, N.J., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s ...
Please provide your email address to receive an email when new articles are posted on . 37.4% of patients with Fitzpatrick skin types IV to VI and 38.7% of the total ...
Wynzora is a combination of calcipotriene, a synthetic vitamin D3 analogue, and betamethasone dipropionate, a corticosteroid. Wynzora ® Cream (calcipotriene 0.005% and betamethasone dipropionate 0.064 ...
Please provide your email address to receive an email when new articles are posted on . WAILEA, Hawaii — A combination calcipotriene and betamethasone dipropionate cream showed similar efficacy in ...
This subgroup analysis shows that skin of color patients treated with CAL/BDP cream have similar efficacy to the total trial population. Patient convenience and satisfaction for CAL/BDP cream were ...
Glenmark has granted final approval from the Food and Drug Administration (FDA) for Clotrimazole and Betamethasone Dipropionate Cream, the generic version of Merck's Lotrisone Cream. Glenmark has ...
Here are three things to know. 1. Betamethasone dipropionate is a topical steroid used to treat itching and other skin conditions, like eczema. 2. The regulatory decision represents Teligent’s first ...
LAKE FOREST, Ill., Oct. 14, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that it received a new Abbreviated New Drug Application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results